ANNJI PHARMACEUTICAL
AnnJi Pharmaceutical is a clinical-stage drug development company that specializes in developing small molecules that address unmet medical needs in the areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy’s disease, and SBMA (Spinal and bulbar muscular atrophy). The focus of the company is on creating global collaborations and business partnerships in the late-stage product development and commercialization of pharmaceutical drugs.
ANNJI PHARMACEUTICAL
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2014-01-01
Address:
Taipei, T'ai-pei, Taiwan
Country:
Taiwan
Website Url:
http://www.ajpharm.com
Total Employee:
11+
Status:
Active
Contact:
+886 2 2365-5677
Email Addresses:
[email protected]
Technology used in webpage:
Euro Google Maps CrUX Dataset Pound Sterling CrUX Top 10m
Similar Organizations
Actimis Pharmaceuticals
Actimis Pharmaceuticals is a biopharmaceutical company developing small molecule therapeutics for respiratory and inflammatory disorders.
ADEL
ADEL is developing therapeutic and diagnostic agents for neurological diseases, particularly Alzheimer's disease.
AUTOTAC Bio
AUTOTAC Bio is a drug development company that creates protein target decomposition drugs for humans.
Avixgen
Avixgen is a drug development company that improves human health through the development of drugs and treatments.
Naturewise Biotech & Medicals Corp
Naturewise Biotech & Medicals Corp is a drug development company which focuses research on the botanical drug and small molecule therapies.
PhytoHealth
PhytoHealth is a drug development company that works to develop new drugs in compliance with international standards and regulations.
RIBOMIC
R&D medicine based on their own platform for developing medicine
Official Site Inspections
http://www.ajpharm.com Semrush global rank: 15.54 M Semrush visits lastest month: 2
Unable to get host informations!!!

More informations about "AnnJi Pharmaceutical"
About Us - ajpharm.com
Dr. Wendy Huang Joined AnnJi as President and CEO in March 2019. Dr. Huang worked in multinational pharmaceutical companies for 40 years and held several leadership and …See details»
AnnJi Pharmaceutical Co. Ltd
Founded in 2014, AnnJi Pharmaceutical Co., Ltd. (AnnJi) is an R&D based, clinical-stage new drug company dedicated to the development of first-in-class small molecules focusing on indications with highly unmet needs in the …See details»
Meet Our Board Members - ajpharm.com
The Secretary-General of Taiwan Biotech Association, a non-profit organization, from 2005 to 2008. Calvin Tsai Director of the Board / CEO of Orient EuroPharma CO., Ltd.See details»
AnnJi Pharmaceutical - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +886 2 2365-5677 AnnJi Pharmaceutical is a clinical-stage drug development company that specializes in developing small molecules …See details»
Annji Pharmaceutical Co., Ltd. - Drug pipelines, Patents ... - Patsnap
Www.ajpharm.com. Startups | Public Company | 2014 | Taiwan Province, China | 10-50 | www.ajpharm.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational …See details»
Annji Pharmaceutical Co. Ltd. (Taiwan, China) - EMIS
Jul 27, 2024 The Company is a Taiwan-based company mainly focuses on innovative new drug projects with high chances of success, concentrates resources on the development of three …See details»
AnnJi Pharmaceutical Co. Ltd. - VentureRadar
IL-11, a member of the IL-6 family of cytokines, is a central mediator of fibrosis and blocking its activity has the potential to be safer than and additive to other anti-fibrotic therapeutic …See details»
Annji Pharmaceutical Co. Ltd. 公司概况 - 中国台湾地区 | 财务及主 …
Jul 27, 2024 The Company is a Taiwan-based company mainly focuses on innovative new drug projects with high chances of success, concentrates resources on the development of three …See details»
AnnJi Pharmaceutical - Overview, News & Similar companies
Who is AnnJi Pharmaceutical. Founded in 2014, AnnJi Pharmaceutical Co., Ltd. (AnnJi) is an R&D based, clinical-stage new drug company dedicated to the development of first-in-c lass …See details»
AnnJi Pharma Company Profile 2024: Stock Performance
AnnJi Pharma General Information Description. Annji Pharmaceutical Co Ltd is an R&D based, clinical-stage new drug company dedicated to the development of first-in-class small …See details»
Meet Our Team - ajpharm.com
Dr. Huang built a forty-year pharmaceutical career across multiple therapeutic areas, medical devices, and cosmetic products. She has a strong track record in global product development and …See details»
AJPHARM LTD overview - Find and update company information
More for AJPHARM LTD (06999357) Registered office address 160 Gillett Road, Thornton Heath, Surrey, CR7 8SN . Company status Active Company type Private limited Company …See details»
AnnJi Pharmaceutical Announced A Licensing Agreement With …
Mar 10, 2023 For more information, visit https://www.ajpharm.com. SOURCE AnnJI. TAIPEI, March 10, 2023 /PRNewswire/ -- AnnJi Pharmaceutical Co. (AnnJi) has entered into an …See details»
AnnJi Pharmaceutical Announced A Licensing Agreement With …
TAIPEI, March 10, 2023 /PRNewswire/ -- AnnJi Pharmaceutical Co. (AnnJi) has entered into an exclusive license agreement with Avenue Therapeutics Inc. (Avenue, NASDAQ: ATXI) for the …See details»
安基生技新药-动脉网 - vbdata.cn
Jan 1, 2014 安基生技新药股份有限公司为一临床阶段之新药开发公司。安基专注于创新小分子(NCE)的开发,目前锁定神经病变、皮肤疾病及免疫发炎性相关疾病领域,开发具有高度医 …See details»
Annji Pharmaceutical Co., Ltd. (安基生技新药股份有限公司) - 药物 …
了解Annji Pharmaceutical Co., Ltd. (安基生技新药股份有限公司)公司的药物管线,治疗领域,技术平台,以及它的3项临床试验, 16篇新闻和2篇文献,疾病领域:神经系统疾病,免疫系统疾病, …See details»
AnnJi Pharmaceutical Investors - ajpharm.com
[email protected] Taiwan’s leading new drug developer in dermatology & neurology. Translation and development of new chemical entities from lead optimization, candidate …See details»
A & J Pharmaceutical - Facebook
A & J Pharmaceutical. 1,936 likes · 5 talking about this. We manufacture different kinds drugs antimalarial, anesthetic and antibioticsSee details»
AJ201 - ajpharm.com
AJ201 is a new chemical entity being developed for the treatment of spinal and bulbar muscular atrophy (SBMA), a neurodegenerative disease associated with abnormal aggregation of the …See details»
Press Release - ajpharm.com
Aug 2, 2023 2024-05-16 – Topline results of the Phase 1b/2a clinical trial anticipated mid-year 2024 – Miami – May 16, 2024 – Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the …See details»